Rituximab
Brands containing Rituximab, food notes, and the most important drug interactions.
BRANDS
11- MABTHERA 100 MG 2 FLAKONbarcode: 8699505763361
- MABTHERA 1400 MG/11,7 ML SC ENJEKSIYON ICIN COZELTI ICEREN 1 FLAKONbarcode: 8699505772813
- MABTHERA 500 MG 1 FLAKONbarcode: 8699505763378
- REDDITUX 100 MG/10 ML INFUZYON COZELTESI HAZIRLAMAK ICIN KONSANTRE COZELTIbarcode: 8680885576016
- REDDITUX 500 MG/50 ML INFUZYON COZELTESI HAZIRLAMAK ICIN KONSANTRE COZELTIbarcode: 8680885576023
- RIXATHON 100 MG/10 ML INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTREbarcode: 8681428761449
- RIXATHON 500 MG/10 ML INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTREbarcode: 8681428761463
- RUXIENCE 100 MG/10 ML I.V. INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTRE barcode: 8681308771032
- RUXIENCE 500 MG/50 ML I.V. INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTREbarcode: 8681308771049
- TRUXIMA 100 MG/10 ML IV INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTRE (2 FLAKON)barcode: 8680614140143
- TRUXIMA 500 MG/50 ML IV INFUZYON ICIN KONSANTRE COZELTI ICEREN FLAKONbarcode: 8680614140129
FOOD NOTES
0No food notes on record for this active ingredient.
MOST IMPORTANT INTERACTIONS
first 10 of 50- AbciximabMAJOR
The risk or severity of bleeding can be increased when Abciximab is combined with Rituximab.
Expert view
- AlteplaseMAJOR
The risk or severity of bleeding can be increased when Alteplase is combined with Rituximab.
Expert view
- AnistreplaseMAJOR
The risk or severity of bleeding can be increased when Anistreplase is combined with Rituximab.
Expert view
- BivalirudinMAJOR
The risk or severity of bleeding can be increased when Bivalirudin is combined with Rituximab.
Expert view
- Drotrecogin alfaMAJOR
The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Rituximab.
Expert view
- EptifibatideMAJOR
The risk or severity of bleeding can be increased when Eptifibatide is combined with Rituximab.
Expert view
- LepirudinMAJOR
The risk or severity of bleeding can be increased when Lepirudin is combined with Rituximab.
Expert view
- ReteplaseMAJOR
The risk or severity of bleeding can be increased when Reteplase is combined with Rituximab.
Expert view
- (R)-warfarinMAJOR
The risk or severity of bleeding can be increased when (R)-warfarin is combined with Rituximab.
Expert view
- (S)-WarfarinMAJOR
The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Rituximab.
Expert view